Treatment of proliferative sparganosis with mebendazole and praziquantel.
D000328:Adult; D001562:Benzimidazoles / Q000627:therapeutic use*; D006801:Humans; D007546:Isoquinolines / Q000627:therapeutic use*; D008297:Male; D008463:Mebendazole / Q000627:therapeutic use*; D011223:Praziquantel / Q000009:adverse effects / Q000627:therapeutic use*; D013031:Sparganosis / Q000188:drug therapy*; D013610:Tachycardia / Q000139:chemically induced
D001562:Benzimidazoles; D007546:Isoquinolines; D011223:Praziquantel; D008463:Mebendazole